Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxiu Hu

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|March 11, 2011
Analysis of missing mechanism in IVUS imaging clinical trials with missing covariatesMingxiu Hu, Tianyue Zhou
Pharmaceutical Statistics|November 27, 2015
Testing multiple primary endpoints in clinical trials with sample size adaptationYi Liu, Mingxiu Hu
The AAPS Journal|June 27, 2006
An automated process for building reliable and optimal in vitro/in vivo correlation models based on Monte Carlo simulationsSteven C Sutton, Mingxiu Hu
Contemporary Clinical Trials|November 9, 2020
Statistical adaptation to oncology drug development evolutionMingxiu Hu, Miao Yang, Yi Liu
Journal of Biopharmaceutical Statistics|July 11, 2019
<i>Z</i><sub>max</sub> test for delayed effect in immuno-oncology clinical trialsMiao Yang, Zhaowei Hua, Lan Xue, et al.
Clinical Trials (London, England)|September 13, 2007
Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomesMingxiu Hu, Joseph C Cappelleri, K K Gordon Lan
American Journal of Clinical Pathology|June 6, 2002
Probability-based construction of reference ranges for ratios of log-gaussian analytes: an example from automated leukocyte countsDonald C Trost, Mingxiu Hu, Allison G Brailey, et al.
Contemporary Clinical Trials|July 9, 2008
Daily process methodology for measuring earlier antidepressant responseWilliam R Lenderking, Mingxiu Hu, Howard Tennen, et al.
The American Journal of Cardiology|January 21, 2011
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter regionJim Gilbert, Julie Lekstrom-Himes, Debra Donaldson, et al.
Lancet (London, England)|March 8, 2025
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in ChinaAnwen Xiong, Lei Wang, Jianhua Chen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|March 11, 2011
Analysis of missing mechanism in IVUS imaging clinical trials with missing covariatesMingxiu Hu, Tianyue Zhou
Pharmaceutical Statistics|November 27, 2015
Testing multiple primary endpoints in clinical trials with sample size adaptationYi Liu, Mingxiu Hu
The AAPS Journal|June 27, 2006
An automated process for building reliable and optimal in vitro/in vivo correlation models based on Monte Carlo simulationsSteven C Sutton, Mingxiu Hu
Contemporary Clinical Trials|November 9, 2020
Statistical adaptation to oncology drug development evolutionMingxiu Hu, Miao Yang, Yi Liu
Journal of Biopharmaceutical Statistics|July 11, 2019
<i>Z</i><sub>max</sub> test for delayed effect in immuno-oncology clinical trialsMiao Yang, Zhaowei Hua, Lan Xue, et al.
Clinical Trials (London, England)|September 13, 2007
Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomesMingxiu Hu, Joseph C Cappelleri, K K Gordon Lan
American Journal of Clinical Pathology|June 6, 2002
Probability-based construction of reference ranges for ratios of log-gaussian analytes: an example from automated leukocyte countsDonald C Trost, Mingxiu Hu, Allison G Brailey, et al.
Contemporary Clinical Trials|July 9, 2008
Daily process methodology for measuring earlier antidepressant responseWilliam R Lenderking, Mingxiu Hu, Howard Tennen, et al.
The American Journal of Cardiology|January 21, 2011
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter regionJim Gilbert, Julie Lekstrom-Himes, Debra Donaldson, et al.
Lancet (London, England)|March 8, 2025
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in ChinaAnwen Xiong, Lei Wang, Jianhua Chen, et al.
Pageof 2